• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Featured / Updated COVID-19 boosters get FDA emergency use authorisation; The latest health stories from around the world

Updated COVID-19 boosters get FDA emergency use authorisation; The latest health stories from around the world

September 6, 2022 By Lalita Panicker Leave a Comment

Booster COVID-19 VaccineThe U.S. Food and Drug Administration (FDA) has granted an emergency use authorization for Moderna’s and Pfizer-BioNTech’s updated booster vaccines, which target the BA.4/BA.5 coronavirus subvariants. www.science.org/content/article/omicron-booster-shots-are-coming-lots-questions?

For the first time since the start of the pandemic, COVID-19 vaccines look set to receive an update. Boosters reformulated to protect against the Omicron variant, which has dominated globally since early this year, may get deployed on both sides of the Atlantic Ocean as early as this month.

The United Kingdom has already authorised a shot produced by vaccine maker Moderna against the Omicron subvariant BA.1 and may start using it soon. Last week, after Science went to press, the European Medicines Agency (EMA) was set to review applications for Moderna’s BA.1 vaccine and another from the Pfizer-BioNTech collaboration.

But BA.1 is no longer circulating; the BA.4 and BA.5 subvariants eclipsed it in the spring. In June, the FDA asked manufacturers to develop a booster specifically targeting those two subvariants, and last week, both Moderna and the Pfizer-BioNTech collaboration said they have submitted data about their BA.4/BA.5 vaccines to the FDA. President Joe Biden’s administration has already placed an order for 170 million doses of such vaccines. (Pfizer and BioNTech have also submitted the data to the EMA; the European Union could first approve a BA.1-based booster and switch to BA.4/BA.5 vaccines later.)

The data on the updated boosters are limited, however, and the impact they will have if greenlit is unclear.

////

The average life expectancy of Americans fell precipitously in 2020 and 2021, the sharpest two-year decline in nearly 100 years and a stark reminder of the toll exacted on the nation by the continuing coronavirus pandemic. www.nytimes.com/2022/08/31/health/life-expectancy-covid-pandemic.html?

In 2021, the average American could expect to live until the age of 76, federal health researchers reported last Wednesday. The figure represents a loss of almost three years since 2019, when Americans could expect to live, on average, nearly 79 years.

The reduction has been particularly steep among Native Americans and Alaska Natives, the National Centre for Health Statistics (NCHS) reported. Average life expectancy in those groups was shortened by four years in 2020 alone.

The cumulative decline since the pandemic started, more than six-and-a-half years on average, has brought life expectancy to 65 among Native Americans and Alaska Natives — on par with the figure for all Americans in 1944.

While the pandemic has driven most of the decline in life expectancy, a rise in accidental deaths and drug overdoses also contributed, as did deaths from heart disease, chronic liver disease and cirrhosis, the new report found.

Meanwhile national test results released last Thursday showed in stark terms the pandemic’s devastating effects on American schoolchildren, with the performance of 9-year-olds in math and reading dropping to the levels from two decades ago. www.nytimes.com/2022/09/01/us/national-test-scores-math-reading-pandemic.html?

This year, for the first time since the National Assessment of Educational Progress tests began tracking student achievement in the 1970s, 9-year-olds lost ground in math, and scores in reading fell by the largest margin in more than 30 years.

The declines spanned almost all races and income levels and were markedly worse for the lowest-performing students. While top performers in the 90th percentile showed a modest drop — three points in math — students in the bottom 10th percentile dropped by 12 points in math, four times the impact.

////

India’s Minister of Science and Technology Dr Jitendra Singh on Thursday (September 1), announced the scientific completion of Cervavac, India’s first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine for the prevention of cervical cancer. https://indianexpress.com/article/explained/explained-health/explained-cervavac-indias-first-indigenously-developed-vaccine-for-cervical-cancer-8125663/

Despite being largely preventable, cervical cancer is the fourth most common cancer among women globally, according to the World Health Organization (WHO). In 2018, an estimated 570,00 women were diagnosed with the disease and it accounted for 311,000 deaths across the world.

Dr Rajesh Gokhale, Secretary of the Government of India’s Department of Biotechnology, and Chairperson of the Biotechnology Industry Research Assistance Council (BIRAC) told The Indian Express that the vaccine would be launched later this year. “As per indications from Serum Institute of India the cost would approximate between Rs 200 to 400,” he said in an interview.

India accounts for about a fifth of the global burden of cervical cancer, with 123,000  cases and 67,000 deaths per year.

Cervavac was developed by the Pune-based Serum Institute of India (SII) in coordination with the Government of India’s Department of Biotechnology (DBT). SII is the world’s largest vaccine manufacturer.

Cervavac received market authorisation approval from the Drug Controller General of India on July 12 this year.

HPV vaccines are given in two doses and data has shown that the antibodies that develop after both are administered can last up to six or seven years, according to Dr. Rajesh Gokhale. Unlike COVID vaccines, booster shots may not be required for the cervical cancer vaccine, he added.

////

Lalita Panicker is Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi

 

Filed Under: Access to Healthcare, Featured, Featured Story, Government policy, Infectious diseases, International, News Tagged With: Cervavac, COVID-19, FDA, HPV

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • Renewed fears of a bird flu pandemic; The latest health stories from around the world
  • More oversight needed for “gain of function” research says expert panel; The latest health stories from around the world
  • Marion Biotech to be investigated by Indian drug regulator
  • Sesame to be added to list of major food allergens
  • Approval of Alzheimer’s drug “rife with irregularities”

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2023 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.